Status:
UNKNOWN
Oxygenation Targets in Cardiac Surgery Patients - a Before-and-after Study
Lead Sponsor:
Aalborg University Hospital
Collaborating Sponsors:
University of Aarhus
Conditions:
Hyperoxia
Cardiac Surgery
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
During surgery high concentrations of supplementary oxygen are routinely administrated. However, there is increasing evidence of potential harm with liberal oxygen therapy. The hypothesis of the prese...
Detailed Description
Background Oxygen is essential to life and supplementary oxygen therapy is routinely administrated during surgery to avoid life-threatening hypoxemia. Supplementary oxygen therapy is often given as a ...
Eligibility Criteria
Inclusion
- Scheduled for elective cardiac surgery either coronary artery bypass grafting and/or valve replacement performed with use of cardiopulmonary bypass
Exclusion
- Left ventricular ejection fraction below 30 percent
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04133740
Start Date
October 1 2018
End Date
July 31 2020
Last Update
October 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Intensive Care, Aalborg University Hospital
Aalborg, Denmark, 9000